Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DNQX (FG 9041) is a competitive, non-NMDA glutamate receptor antagonist (IC50s = 0.5 and 0.1 μM for AMPA and kainate receptors, respectively)
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | In stock | $ 51.00 | |
50 mg | In stock | $ 82.00 | |
100 mg | In stock | $ 117.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 50.00 |
Description | DNQX (FG 9041) is a competitive, non-NMDA glutamate receptor antagonist (IC50s = 0.5 and 0.1 μM for AMPA and kainate receptors, respectively) |
In vitro | DNQX has been used to specifically target AMPA and kainate receptor responses and thus differentiate from that of NMDA receptors. DNQX does not stimulate a robust long-term potentiation in the hippocampus[1] |
Synonyms | FG 9041 |
Molecular Weight | 252.14 |
Formula | C8H4N4O6 |
CAS No. | 2379-57-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 35 mg/mL (138.81 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DNQX 2379-57-9 Membrane transporter/Ion channel Neuroscience GluR iGluR inhibit nucleus selective thalamic Ionotropic glutamate receptors FG 9041 Inhibitor quinoxaline FG9041 non-NMDA competitive reticular FG-9041 inhibitor